PHEOCHROMOCYTOMA
Clinical trials for PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental vaccine trial for rare adrenal cancers halted early
Disease control TerminatedThis early-stage trial tested a new therapeutic vaccine (EO2401) combined with immune-boosting drugs in 70 people with advanced adrenal gland cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the combination was safe and could …
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Experimental cancer drug SGI-110 tested in rare tumors – study halted early
Disease control TerminatedThis study tested the drug SGI-110 in people aged 12 and older with rare cancers like wild-type GIST, pheochromocytoma, paraganglioma, or HLRCC kidney cancer that had not responded to other treatments. The goal was to see if the drug could shrink tumors or slow their growth. The …
Matched conditions: PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:30 UTC